Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/06/053362
CTRI/2023/06/053362
Not yet recruiting
Phase 4

A clinical prospective, double blinded randomized controlled study to compare Intrathecal Hyperbaric Ropivacaine Hydrochloride 0.75%(3ml) plus Fentanyl with Intrathecal Hyperbaric Ropivacaine Hydrochloride0.75%(3ml) plus Tramadol for infraumbilical surgeries.

Pacific medical college and hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K353- Acute appendicitis with localizedperitonitisHealth Condition 2: N211- Calculus in urethraHealth Condition 3: N701- Chronic salpingitis and oophoritisHealth Condition 4: S720- Fracture of head and neck of femurHealth Condition 5: S828- Other fractures of lower legHealth Condition 6: K409- Unilateral inguinal hernia, without obstruction or gangrene

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K353- Acute appendicitis with localizedperitonitisHealth Condition 2: N211- Calculus in urethraHealth Condition 3: N701- Chronic salpingitis and oophoritisHealth Condition 4: S720- Fracture of head and neck of femurHealth Condition 5: S828- Other fractures of lower legHealth Condition 6: K409- Unilateral inguinal hernia, without obstruction or gangrene
Sponsor
Pacific medical college and hospital
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pacific medical college and hospital

Eligibility Criteria

Inclusion Criteria

  • •1 All patients of age group between 20 and 60 years of either sex.
  • •2 Patients belonging to American Society of Anaesthesiologists (ASA ) grade I and grade II.
  • •3 Patients posted for infraumbilical surgeries.

Exclusion Criteria

  • •1\.ASA Grade \>\=III
  • •2\.Mental retardation (congenital anomaly) patients
  • •3\.Those with bleeding disorders and local sepsis,
  • •4\.Those on anti\-coagulants and anti\-platelet agents,
  • •5\.Those allergic to local anesthetic,
  • •6\.Patient refusal for the procedure and technical difficulties

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical trial to access change in gut immunity of healthy subjects for efficacy and safety of formulation (s).
CTRI/2018/05/013813ITC Life Sciences and Technology Center250
Recruiting
Not Applicable
Antibody response after Covid-19 vaccine alongwith Kabasura Kudineer
CTRI/2021/05/033857Sri Sri Institute of Advance Research
Not yet recruiting
Not Applicable
Antibody response after COVID 19 vaccine provided along with ayurvedic medicine (NOQ19)
CTRI/2021/12/038587Sri Sri Institute of Advance Research SSIAR
Not yet recruiting
Not Applicable
A study comparing 2 drugs in reversal of general anaesthesia
CTRI/2023/10/058419SIMS hospitals, Department of anaesthesiology and pain management
Withdrawn
Not Applicable
A prospective randomised double-blind, double-dummy, placebo-controlled crossover study to determine whether Glucagon-like peptide-1 (GLP-1) stimulates or suppresses pancreatic exocrine function in health.
ACTRN12614000815662Dr Adam Deane15